Bugün 06 Ağustos 2025 Çarşamba

TÜRKİYE PROBİYOTİK REHBERİ

Filtrele
Sıfırla
Ticari Marka Probiyotik Mikroorganizma İçeriği Ticari Form KOB (CFU) Günlük Önerilen Kullanım Miktarı Yaş/Cinsiyet Kaynağa Dayalı Destek Kullanım Alanı-Kaynağa Göre Kanıt Düzeyi
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek 1 (1)-- https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/caros/oroduct-caros/lactocacillus-acicoonilus-la-5 --(2)--https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/cards/product-cards/bifidobacterium-animalis-subsp-lactis-bb-12 --(3)-- https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/caros/oroduct-caros/lactocacillus-paracasel-suosp-paracasel-l-casel-431 --(4)-- https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/cards/product-cards/lactobacilus-rhamnosus-gg-trademark-lgg --(5)-- https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/caros/product-caros/streotococcus-tnermoonilus-th-4
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek 1 (1)--https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/caros/oroduct-caros/lactocacillus-acicoonilus-la-5 --(2)--https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/cards/product-cards/bifidobacterium-animalis-subsp-lactis-bb-12
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek 1 (1)--https://www.chr-hansen.corn/en/probiotic-supplements-and-infant-formula/cards/product-cards/lactobacillus-acidophilus-la-5 --(2)--https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/cards/product-cards/bifidobacterium-animalis-subsp-lactis-bb-12 --(3)--https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/cards/product-cards/lactobacillus-paracasei-subsp-paracasei-l-casei-431 --(4)-- https://www.chr-hansen.com/en/probiotic-supplernents-and-infant-formula/cards/product-cards/lactobacillus-rhamnosus-gg-trademark-Igg
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
İBS (İritable Bağırsak Sendromu) 1 Güncelleniyor
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek T.C. TARIM VE ORMAN BAKANLIĞI PMOL listesi kapsamındadır
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
İBS (İritable Bağırsak Sendromu) 1 (1)--Ritchie, M. L.; Romanuk , T. NA. (2012) A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE, 7(4), 1-11. --(2)-- 2-Mc Farland L. V. (2008) A Meta-Analysis of Probiotics for the Treatment of Irritable Bowel Syndrome, World Journal of Gastroenterology, 14(17), 2650-2661.
İmmün sistemi desteklemek 1 Ritchie, M. L.; Romanuk , T. NA. (2012) A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE, 7(4), 1-11.
İBH (İnflamatuvar Bağırsak Hastalığı) 1 Ritchie, M. L.; Romanuk , T. NA. (2012) A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE, 7(4), 1-11.
Sindirim sistemini düzenlemek 1 Scientific Opinion on the substantiation of a health claim related to Saccharomyces cerevisiae var. boulardii CNCM I-3799 and reducing gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Journal 2012; 10(7):2801
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
İnfantil Kolik 1 Güncelleniyor
Akut Diyare 1 Güncelleniyor
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Akut Diyare 1 (1)--Szajewska, H.; Guarino, A.; Hojsak, I.; Indrio, F.; Kolacek, S.; Shamir, R.; Vandenplas, Y.; Weizman, Z. 1 (2014) The Use of Probiotics for The Management of Acute Gastroenteritis. A Position Paper by the ESPGHAN Working Group for Probiotics. J Pediatr Gastroenterol Nutr., 58, 531-539. Online 23 Jan. 2014, doi: 10.1097/MPG.0000000000000320. [L reuteri ATCC 55730 and DSM 17938] --(2)-- Urbanska, M.; Gieruszczak-Bialek, D.; Szajewska, H. (2016) Systematic Review with Meta-analysis: 1 Lactobacillus reuteri DSM 17938 for Diarrhoea! Diseases in Children. Aliment Pharmacol Then., 43(10),1025-34. doi:10.1111/apt.13590 --(3)--Agustina, R.; Kok, FJ.; van de Rest, 0.; Fahmida, U.; Firmansyah, A.; Lukito, W.; Feskens, EJM.; can den 1 Heuvel, EGHM.; Albers, R.; Bovee-Oudenhoven, IMJ. (2012). Randomized Trial of Probiotics and Calcium on Diarrhea and Respiratory Tract Infections in Indonesian Children. Pediatrics, 129, e1155-e1164. (L. reuteri DSM 17938) --(4)--Gutierrez-Castrellon, P.; Lopez-Velazquez, G.; Diaz-Garcia, L; Jimenez-Gutierrez, C.; Mancilla¬1 Ramirez, J.; Estevez-Jimenez, J.; Parra, M. (2014) Diarrhea in Preschool Children and Lactobacillus muted: A Randomized Controlled Trial. Pediatrics, 133, e904-e909. (L. reuteri DSM 17938) Free access: http://pediatrics.aappublications.org/content/133/4/e904 --(5)--Dinleyici, EC.; PROBAGE Study Group; Vandenplas, Y. (2014) Lactobacillus reuteri DSM 17938 1 Effectively Reduces The Duration of Acute Diarrhoea in Hospitalised Children. Acta Paediatr., 103, e300-e305. --(6)--Dinleyici, EC.; Dalgic, N.; Guven, S.; Metin, 0.; Yasa, 0.; Kurugol, Z.; Turel, O.; Tanir, G.; Yazar, AS.; Arica, V.; Sancar, M.; Karbuz, A.; Eren, M.; Ozen, M.; Kara, A.; Vandenplas, Y. (2015) Lactobacillus reuteri 1 DSM 17938 Shortens Acute Infectious Diarrhea in A Pediatric Outpatient Setting. J Pediatr (Rio .), 91, 392¬396. (Part of the Dinleyici study of 2014, analysis of outpatient subjects.) Free access at http://www.sciencedirect.com/science/article/pii/S
İnfantil Kolik 1 Anabrees, J.; Indrio, F.; Paes, B.; AlFaleh, K. (2013) Probiotics for Infantile Colic: A Systematic Review. BMC Pediatrics, 13:186.
İnfantil Kolik 1 Cameron, D.; Hock, QS.; Kadim, M.; Mohan, N.; Ryoo, E.; Sandhu, B.; Yamashiro, Y.; Jie, C.; Hoekstra, 1 H.; Guarino, A. (2017) Probiotics for Gastrointestinal Disorders: Proposed Recommendations for Children of the Asia-Pacific Region. World J Gastroenterol, 23(45), 7952-7964. --(2)-- Cruchet, S.; Furnes, R.; Maruy, A.; Hebei, E.; Palacios, J.; Medina, F.; Ramirez, N.; Orsi, M.; Rondon, L.; 1 Sdepanian, V.; Xdchihua, L.; Ybarra, M.; Zablah, RA. (2015) The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Paediatr Drugs, 17, 199-216. --(3)-- Dryl, R.; Szajewska, H. (2018) Probiotics for Management of Infantile Colic: A Systematic Review of Randomized Controlled Trials. Arch Med Sci, 14, 1137-1143.
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Akut Diyare 1 Güncelleniyor
İnfantil Kolik 1 Güncelleniyor
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek T.C. TARIM VE ORMAN BAKANLIĞI PMOL listesi kapsamındadır
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Sindirim sistemini düzenleyerek bağışıklık sistemini desteklemek T.C. TARIM VE ORMAN BAKANLIĞI PMOL listesi kapsamındadır
Kaynağa Dayalı Destek Kullanım Alanları
Destek Alanı Seviye Kaynak
Ürogenital Sistem Enfeksiyonu 1 (1)--Anukam, K.C.; E. Osazuwa, G.I.; Osemene, F.; Ehigiagbe, A.W.; Bruce, and G. Reid. Clinical Study 1 Comparing Probiotic Lactobacillus GR-1 and RC-14 with Metronidazole Vaginal Gel to Treat Symptomatic Bacterial Vaginosis. (2006) Microbes and Infection, 8.12, 2772-2776. --(2)-- Hummelen, R.; J. Changalucha, N.L.; Butamanya, A.; Cook, J.D.F.; Habbema, and G. Reid. 1 (2010) Lactobacillus rhamnosus GR-1 and L reuteri RC-14 to Prevent or Cure Bacterial Vaginosis Among Women with HIV. International Journal of Gynecology & Obstetrics, 111.3,245-248. --(3)--Reid, G. A.W.; Bruce, N.; Fraser, C.; Heinemann, J.; Owen, and B. Henning. "Oral Probiotics Can Resolve Urogenital Infections. (2001)FEMS Immunology & Medical Microbiology, 30.1, 49-52. --(4)--Anukam, K.; E. Osazuwa, I.; Ahonkhai, M.; Ngwu, G.; Osemene, A.W.; Bruce, and G. Reid. Augmentation of Antimicrobial Metronidazole Therapy of Bacterial Vaginosis with Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, Double-blind, Placebo Controlled Trial. (2006) Microbes and Infection, 8.6, 1450-1454. --(5)--Martinez, R.C.; S.A. Franceschini, MC.; Patta, S.M.; Quintana, B.C.; Gornes, E.C.; De Martinis, and G. Reid. Improved Cure of Bacterial Vaginosis with Single Dose of Tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus muted RC-14: A Randomized, Double-blind, Placebo-controlled Trial. (2009) Canadian Journal of Microbiology, 55.2, 133-138. --(6)--Vujic, G.; A.J.; Knez, V.D.; Stefanovic, and V.K. Vrbanovic. Efficacy of Orally Applied Probiotic Capsules for Bacterial Vaginosis and Other Vaginal Infections: A Double-blind, Randomized, Placebo-controlled Study. (2013) European Journal of Obstetrics & Gynecology and Reproductive Biology, 168.1,75-79. --(7)--Martinez, R.C.; S. A.; Franceschini, M. C.; Patta, S. M.; Quintana, R. C.; Candido, J. C.; Ferreira, E C. P. De Martinis, and G. Reid. Improved Treatment of Vulvovaginal Candidiasis with Fluconazole Plus Probiotic Lactobacillus rhamnosus G
Vajinal Flora Restorasyonu 1 57- Reid, G.; D. Charbonneau, J.; Erb, B.; Kochanowski, D.; Beuerman, R.; Poehner, and A.W. Bruce. (2003) Oral Use of Lactobacillus rhamnosus GR-1 and L. ferrnenturn RC-14 Significantly Alters Vaginal Flora: Randomized, Placebo-controlled Trial in 64 Healthy Women. FEMS Immunology & Medical Microbiology, 35.2, 131-134.